Total Funding
75
60
Total FundingSeries B raised
Growth Score 75 in past quarter
-14 pts
Heat Score 60 in past quarter
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
10101
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.
- Andrew Farnum: CEO
- Stephane Castel: Co-Founder & Chief Technology OfficerPast Role: Fiix Software, Co-Founder
About the Company
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics. The company's focus is to identify individuals and populations around the world who are extreme outliers for traits of medical relevance and to use innovative sequencing and analytic approaches to identify genes and pathways linked to these traits.
Variant Bio was founded in 2018 and headquartered in Seattle, Washington.
Women Founded